Paragonix Technologies Inc. Announces Publication by the ASAIO (American Society for Artificial Internal Organs) Journal of “Oxygen Consumption During Oxygenated Hypothermic Perfusion as a Measure of Donor Organ Viability”

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BRAINTREE, Mass.--(BUSINESS WIRE)--Paragonix Technologies, Inc. today announced that the American Society for Artificial Internal Organs (ASAIO) Journal has published an original research paper describing the performance of a hypothermic perfusion platform for donor organ preservation and the ability to monitor donor organ viability. The study concludes that measurement of organ oxygen consumption during oxygenated hypothermic perfusion may have significant value in predicting post- preservation organ function.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC